Guardant Health

----

Current ValuationThe current P/E ratio is -52.92, below the reasonable range, cheaper than 97.7% of the time in the past 1 years, and the industry ranks 58/74, the industry Median --.

-52.92xP/E

Stock price$178.80Earnings per share$-3.38

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

08162432

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
GHUSGuardant Health	-52.92x	3.12%	$23.99B
HIMSUSHims & Hers Health	-45.47x	209.86%	$6.46B
RDNTUSRadnet	-273.89x	128.00%	$5.78B
NEOUSNeogenomics	-69.14x	69.76%	$2.23B
WGSUSGeneDx	-19.36x	359.59%	$2.06B
AGLUSagilon health	-6.14x	92.48%	$1.43B
INNVUSInnovage	-494.28x	2,301.70%	$1.25B
OPKUSOpko Health	-17.00x	25.99%	$1.24B
CSTLUSCastle Biosciences	-58.47x	50.00%	$1.14B
LMRIUSLumexa Imaging	-39.53x	145.51%	$1.10B
AONCUSAmerican Oncology Network	--	--	$746.52M
GMRSUSGMR Solutions	-7.99x	91.45%	$604.50M
FLGTUSFulgent Genetics	-6.72x	42.64%	$567.37M
PREUSPrenetics Global	-6.48x	17.18%	$304.47M
BDSXUSBiodesix	-8.84x	42.80%	$245.37M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
AIRSUSAirSculpt Tech	-10.63x	33.33%	$124.72M
GAMGUSGlobal Asset Management Group, Inc.	-203.89x	--	$115.08M
NAKAUSNakamoto	-0.25x	102.50%	$104.86M
PARKUSPark Dental Partners	-28.37x	--	$100.29M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.